In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
Joshua P. Cohen
·
2026-06-08
·
via Forbes - Healthcare
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is haile…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。